Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03984305 · ClinicalTrials.gov registry record · NA
Utilization of Target Ranges to Treat Parkinson's Disease With the PKG
A NA study, sponsored by Global Kinetics Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03984305 is a NA study that was terminated before completion, run by Global Kinetics Corporation. The registered enrollment target is 41 participants.
The verdict
NCT03984305, a NA study, was terminated before completion, sponsored by Global Kinetics Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The main objective of this study is to evaluate whether people whose PD symptoms are uncontrolled who are managed with the aid of objective measurement and use of target ranges have improved PD symptoms and outcomes as compared to individuals treated using only standard of care (medical history, neurological examination).
Interventions
- DEVICE Personal KinetiGraph® (PKG®) Watch
- DEVICE Personal KinetiGraph® (PKG®) Report
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-10-15 |
| Est. Completion | 2020-10-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03984305
The ClinicalTrials.gov registry entry for NCT03984305 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Global Kinetics Corporation, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Personal KinetiGraph® (PKG®) Watch is the first listed.
NCT03984305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03984305 about?
NCT03984305 is a clinical study titled "Utilization of Target Ranges to Treat Parkinson's Disease With the PKG". The main objective of this study is to evaluate whether people whose PD symptoms are uncontrolled who are managed with the aid of objective measurement and use of target ranges have improved PD symptoms and outcomes as compared to individuals treated using only standard of care (medical history, neu...
What is the current status of trial NCT03984305?
This trial is currently terminated. It is a NA study. The enrollment target is 41 participants. The study started on 2019-10-15. Estimated completion is 2020-10-16.
What interventions are being tested in trial NCT03984305?
The interventions under investigation include: Personal KinetiGraph® (PKG®) Watch (DEVICE), Personal KinetiGraph® (PKG®) Report (DEVICE).
Who is sponsoring clinical trial NCT03984305?
This trial is sponsored by Global Kinetics Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.